BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30531568)

  • 21. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
    Dickinson JE; Jennings BG; Doherty DA
    Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
    Chen MJ; Creinin MD
    Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
    Wedisinghe L; Elsandabesee D
    Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.
    Ashok PW; Templeton A; Wagaarachchi PT; Flett GM
    BJOG; 2002 Nov; 109(11):1281-9. PubMed ID: 12452467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
    Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT
    N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
    Gemzell-Danielsson K; Lalitkumar S
    Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion.
    Chai J; Tang OS; Hong QQ; Chen QF; Cheng LN; Ng E; Ho PC
    Hum Reprod; 2009 Feb; 24(2):320-4. PubMed ID: 19049993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability.
    Ngai SW; Tang OS; Chan YM; Ho PC
    Hum Reprod; 2000 May; 15(5):1159-62. PubMed ID: 10783370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
    Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
    Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial.
    Sheldon WR; Durocher J; Dzuba IG; Sayette H; Martin R; Velasco MC; Winikoff B
    Contraception; 2019 May; 99(5):272-277. PubMed ID: 30831103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion.
    Eng NS; Guan AC
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):331-4. PubMed ID: 9325520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical treatments for incomplete miscarriage.
    Neilson JP; Gyte GM; Hickey M; Vazquez JC; Dou L
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007223. PubMed ID: 23543549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.